Why Are So Few Blockbuster Drugs Invented Today?

November 13, 2014

(New York Times) – Of course, an overreliance on genomics is not the only factor slowing down the discovery of new drugs, as industry analysts are quick to point out. One challenge is that the industry is the victim of its own previous successes. In order to thrive, it must come up with drugs that work better than blockbusters of the past. After all, old drugs don’t fade away; they just go generic.

Posted by

Posted in News, Pharma